We needed to understand the answers to these questions before embarking upon our journey to a solution for M. chimaera plagued water found in Cardiac OR’s. What we discovered was:

1. There are too many variables in relying on chemical disinfection alone, whether there is a protocol or not. The FDA has recognized this.
2. Off the shelf UV-C cylinder designs were not maximizing UV-C light reflectivity.
3. Almost EVERY attempt at using UV-C was unsuccessful due to the same misstep. Easy access to off-the- shelf UV-C stock lamps proved to be ineffective at targeting M. chimaera in high flowing water.
4. No previous attempts that utilized UV-C ever successfully validated effectiveness with high flow water and M. chimaera.
5. Until now, UV-C device manufacturers appeared reluctant to supply data supporting validation, which is a usual medical facility quality assurance expectation.
6. None of the 35 UV-C manufacturing and supply companies contacted provided validation data.
7. Most manufacturers offered stock UV-C lamps, referencing reports that cite 20 mJ lamps suffice to eliminate M. chimaera (Which hasn’t worked to efficiently target this robust bacterium in high flow water.)
8. Only one company confirmed they could manufacture and validate our patented proprietary customized UV-accelerated- lamp-technology we knew would be crucial to our success and that is why we partnered with them.